Back
FactSet Research Systems Vs. Edgewise Therapeutics Industry Stock Comparison
Buy
59
FDS
FactSet Research Systems
Last Price:
488.79
Seasonality Move:
-0.2%
Buy
68
EWTX
Edgewise Therapeutics
Last Price:
30.17
Seasonality Move:
30.89%
Buy
59
FactSet Research Systems (FDS)
is a Buy
Is FactSet Research Systems a Buy, Sell or Hold?
- The current FactSet Research Systems [FDS] share price is $487.59. The Score for FDS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- FDS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $32.69. The Score for EWTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FDS Stock Price Chart
What is FactSet Research Systems's stock price today?
-
The FactSet Research Systems share price today is $487.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDS is experiencing selling pressure, which indicates risk of future bearish movement.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $32.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing slight buying pressure.
FDS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.41 | Buy |
| Relative Strength Index (14 RSI): | 56.29 | Buy |
| Chaikin Money Flow: | -172425 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (480.98 - 490.8) | Buy |
| Bollinger Bands (100): | (421.23 - 480.45) | Buy |
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 54.58 | Buy |
| Chaikin Money Flow: | 961676 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.01 - 33.47) | Buy |
| Bollinger Bands (100): | (19.14 - 33.32) | Buy |
FDS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 484.36 | Buy |
| 20-day SMA: | 485.54 | Buy |
| 50-day SMA: | 474.11 | Buy |
| 200-day SMA: | 441.72 | Buy |
| 8-day EMA: | 486.41 | Buy |
| 20-day EMA: | 484.11 | Buy |
| 50-day EMA: | 474.01 | Buy |
| 200-day EMA: | 449.73 | Buy |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.27 | Buy |
| 20-day SMA: | 31.27 | Buy |
| 50-day SMA: | 32.55 | Buy |
| 200-day SMA: | 22.1 | Buy |
| 8-day EMA: | 30.36 | Buy |
| 20-day EMA: | 31.19 | Buy |
| 50-day EMA: | 30.63 | Buy |
| 200-day EMA: | 23.28 | Buy |
FactSet Research Systems Earnings Growth & FDS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.22 per share, and an increase next year of $0.89 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.34 per share.
FactSet Research Systems Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edgewise Therapeutics Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||